The Risk-Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Genseng, Echinacea, Saw Palmetto, and Kava
Ann Int Med 136:42-53, Ernst,E., 2002
Calcium Channels & Calcium Channel Antagonists
Ann Neurol 21:317-330, Greenberg,D.A., 1987
Neurologic Manifestations in Sarcoidosis
Ann Int Med 87:336, Delaney,P., 1977
Neurologic Complications of Polycythemia
Ann Int Med 57:909, Silverstein,A.,et al, 1962
A Middle-Aged Man with Progressive Gait Abnormalities
Neurol 97:e2423-e2428, Lin, J.,et al, 2021
Cerebral Atrophy and Leukoencephalopathy in a Young Man Presenting with Encephalitic Episodes
JAMA Neurol 75:1563-1564, Xiao, F.,et al, 2018
Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia
NEJM 376:2503-2506, Davis, M.C.,et al, 2017
Paraneoplastic and Autoimmune Encephalitis
UptoDate July, Dalmau, J.,et al, 2017
Acquired Hepatocerebral Degeneration
Neurol 87:e144, Bateman, J.R. & Roque, D.A., 2016
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Antipsychosis Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1208, Ropper, A.H.,et al, 2014
Bilirubin-Induced Neurologic Damage - Mechanisms and Management Approaches
NEJM 369:2021-2030, Watchko, J.F.,et al, 2013
Delayed Onset of Progressive Chorea After Acute Basal Ganglia Injury
Mov Disord 28:585-587, Virmani, T.,et al, 2013
Immunotherapy-Responsive Chorea as the Presenting Feature of LGI1-Antibody Encephalitis
Neurol 79:195-196, Tofaris,G.K.,et al, 2012
A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
NEJM 358:1009-1017, Stepens,A.,et al, 2008
Bilateral Basal Ganglia Lesions in Patients with End-Stage Diabetic Nephropathy
Nephrology 13:68-72, Li, J.,et al, 2008
Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003
Acute Dystonic Reactions to "Street Xanax"
NEJM 346:1753, Hendrickson,R.G.,et al, 2002
Out of Africa, Trypanosomiasis
NEJM 347:749-753, Sahlas,D.J.,et al, 2002
Drug-Induced Pisa Syndrome (Pleurothotomus)
CNS Drugs 10:166-174, Suzuki, T. & Matsuzaka, H., 2002
HIV-Related Movement Disorders, Epidemiology, Pathogenesis and Management
CNS Drugs 16:663-668, Cardoso,F., 2002
Neurologic Side Effects in Neuroleptic-Naive Patients Treated with Haloperidol or Risperidone
Neurol 52:782-785, Rosebush,P.I.&Mazurek,M.F., 1999
Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999
Mortality from Parkinson Disease
Arch Neurol 54:260-264, Louis,E.D.,et al, 1997
Corticobasal Degeneration:Neuropathologic and Clinical Heterogeneity
Neurol 48:959-969, Schneider,J.A.,et al, 1997
Cocaine-Associated Dystonic Reaction
Am J Emerg Med 15:513-516, Fines,R.E.,et al, 1997
Extrapyramidal Side Effects with Low-Dose Risperidone
Can J Psychiatry 42:325-325, Brown, E.S., 1997
Movement Disorders Associated with the Serotonin Selective Reuptake Inhibitors
J Clin Psychiatry 57:449-454, Leo,R.J., 1996
Chorea Caused by Lithium Intoxication
Mov Disord 11:733-737, Podskalny, G.D. & Factor, S.A., 1996
Clinical Assessment of Extrapyramidal Signs in Nursing Home Patients Given Antipsychotic Medication
Arch Int Med 154:1113-1117, Avorn,J.,et al, 1994
Risperidone
Lancet 343:457-460, Livingston,M.G., 1994
Extrapyramidal Signs and Other Neurologic Findings in Clinically Diagnosed Alzheimer's Dis, A Community-Based Study
Arch Neurol 50:51-56, Funkenstein,H.H.,et al, 1993
Increase of Parkinson Disability after Fluoxetine Medication
Neurol 43:211-213, Steur,E.N.H.J., 1993
The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Arch Int Med 153:1469-1475, Ganzini,L.,et al, 1993
Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992
Ataxia-Telangiectasia:An Interdisciplinary Approach to Pathogenesis
Medicine 70:99-117, Gatti,R.A.,et al, 1991
Movement Disorders in Alcoholism:A Review
Neurol 40:741-746, Neiman,J.,et al, 1990
Neurological Findings in Alzheimer's Disease and Normal Aging
Arch Neurol 47:625-627, Glasko,D.,et al, 1990
Clinical & PET Studies in the'Extrapyramidal Syndrome'of Dementia of the Alzheimer Type
Arch Neurol 47:1318-1323, Tyrrell,P.J.,et al, 1990
Persistent Dystonia Associated with Buspirone
Neurol 40:1904, Boylan,K., 1990
Cyclosporin-Associated Akinetic Mutism and Extrapyramidal Syndrome after Liver Transplantation
JNNP 53:1068-1071, Bird,G.L.A.,et al, 1990
Lithium Carbonate Intoxication, A Case Report and Review of the Literature
Arch Int Med 149:36-46, Simard,M.,et al, 1989
Movement Disorder of Premature Infants with Severe Bronchopulmonary Dysplasia:A New Syndrome
Pediatrics 84:215-218, Perlman,J.M.&Volpe,J.J., 1989
Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
Metoclopramide-Induced Movement Disorders
Arch Int Med 149:2486-2492, Miller,L.G.&Jankovic,J., 1989
Diphenhydramine-Induced Dystonia
Clin Pharmacy 8:471, Santora,J.,et al, 1989
Extrapyramidal Reactions to Anti-Inflammatory Drugs
JNNP 51:731-732, Wood,N.,et al, 1988
Parkinsonism, Tremor, and Depression Induced by Cinnarizine and Flunarizine
BMJ 297:722-723, Capella,D.,et al, 1988
Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987
Flunarizine- & -Cinnarizine-Induced Extrapyramidal Reactions
Neurol 37:881-884, Micheli,F.,et al, 1987